Persistence Market Research Company
Customize Now Get FREE Sample

Fibroblast Growth Factors Market Size, Share, Growth, and Regional Forecast, 2025 - 2032

Fibroblast Growth Factors Market by Product Type (FGF1, FGF2, FGF7, FGF10,FGF19, FGF21, FGF23, Others), Form (Research Grade, GMP Grade, Finished Formulations, Kits & Diagnostic Reagents), Application (Oncology, Hematology, Wound Healing, Dermatology, Cardiovascular Disease & Diabetes, Cell Therapy, Others), End User (Pharmaceutical & Biotechnology Companies, Research Centers & Academic Institutes, Contract Research & Manufacturing Organizations), and Regional Analysis from 2025 - 2032

ID: PMRREP28315| 199 Pages | 29 Nov 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Fibroblast Growth Factors Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Regulatory Landscape
    2. Product Adoption Analysis
    3. Disease Epidemiology
    4. Value Chain Analysis
    5. Key Deals and Mergers
    6. PESTLE Analysis
    7. Porter’s Five Force Analysis
  4. Global Fibroblast Growth Factors Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
    3. Global Fibroblast Growth Factors Market Outlook: Product
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Product, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
        1. FGF1
        2. FGF2
        3. FGF7
        4. FGF10
        5. FGF19
        6. FGF21
        7. FGF23
        8. Others
      4. Market Attractiveness Analysis: Product
    4. Global Fibroblast Growth Factors Market Outlook: Product Form
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Product Form, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Product Form, 2025 - 2032
        1. Research Grade
        2. GMP Grade
        3. Finished Formulations
        4. Kits & Diagnostic Reagents
      4. Market Attractiveness Analysis: Product Form
    5. Global Fibroblast Growth Factors Market Outlook: Application
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Application, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
        1. Oncology
        2. Hematology
        3. Wound Healing
        4. Dermatology
        5. Cardiovascular Disease & Diabetes
        6. Cell Therapy
        7. Others
      4. Market Attractiveness Analysis: Application
    6. Global Fibroblast Growth Factors Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By End User, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
        1. Pharmaceutical & Biotechnology Companies
        2. Research Centers & Academic Institutes
        3. Contract Research & Manufacturing Organizations
      4. Market Attractiveness Analysis: End User
  5. Global Fibroblast Growth Factors Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
    3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Fibroblast Growth Factors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product
      3. By Product Form
      4. By Application
      5. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
      1. FGF1
      2. FGF2
      3. FGF7
      4. FGF10
      5. FGF19
      6. FGF21
      7. FGF23
      8. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Product Form, 2025 - 2032
      1. Research Grade
      2. GMP Grade
      3. Finished Formulations
      4. Kits & Diagnostic Reagents
    6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Oncology
      2. Hematology
      3. Wound Healing
      4. Dermatology
      5. Cardiovascular Disease & Diabetes
      6. Cell Therapy
      7. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Pharmaceutical & Biotechnology Companies
      2. Research Centers & Academic Institutes
      3. Contract Research & Manufacturing Organizations
    8. Market Attractiveness Analysis
  7. Europe Fibroblast Growth Factors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product
      3. By Product Form
      4. By Application
      5. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
      1. FGF1
      2. FGF2
      3. FGF7
      4. FGF10
      5. FGF19
      6. FGF21
      7. FGF23
      8. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Product Form, 2025 - 2032
      1. Research Grade
      2. GMP Grade
      3. Finished Formulations
      4. Kits & Diagnostic Reagents
    6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Oncology
      2. Hematology
      3. Wound Healing
      4. Dermatology
      5. Cardiovascular Disease & Diabetes
      6. Cell Therapy
      7. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Pharmaceutical & Biotechnology Companies
      2. Research Centers & Academic Institutes
      3. Contract Research & Manufacturing Organizations
    8. Market Attractiveness Analysis
  8. East Asia Fibroblast Growth Factors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product
      3. By Product Form
      4. By Application
      5. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
      1. FGF1
      2. FGF2
      3. FGF7
      4. FGF10
      5. FGF19
      6. FGF21
      7. FGF23
      8. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Product Form, 2025 - 2032
      1. Research Grade
      2. GMP Grade
      3. Finished Formulations
      4. Kits & Diagnostic Reagents
    6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Oncology
      2. Hematology
      3. Wound Healing
      4. Dermatology
      5. Cardiovascular Disease & Diabetes
      6. Cell Therapy
      7. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Pharmaceutical & Biotechnology Companies
      2. Research Centers & Academic Institutes
      3. Contract Research & Manufacturing Organizations
    8. Market Attractiveness Analysis
  9. South Asia & Oceania Fibroblast Growth Factors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product
      3. By Product Form
      4. By Application
      5. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
      1. FGF1
      2. FGF2
      3. FGF7
      4. FGF10
      5. FGF19
      6. FGF21
      7. FGF23
      8. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Product Form, 2025 - 2032
      1. Research Grade
      2. GMP Grade
      3. Finished Formulations
      4. Kits & Diagnostic Reagents
    6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Oncology
      2. Hematology
      3. Wound Healing
      4. Dermatology
      5. Cardiovascular Disease & Diabetes
      6. Cell Therapy
      7. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Pharmaceutical & Biotechnology Companies
      2. Research Centers & Academic Institutes
      3. Contract Research & Manufacturing Organizations
    8. Market Attractiveness Analysis
  10. Latin America Fibroblast Growth Factors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product
      3. By Product Form
      4. By Application
      5. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
      1. FGF1
      2. FGF2
      3. FGF7
      4. FGF10
      5. FGF19
      6. FGF21
      7. FGF23
      8. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Product Form, 2025 - 2032
      1. Research Grade
      2. GMP Grade
      3. Finished Formulations
      4. Kits & Diagnostic Reagents
    6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Oncology
      2. Hematology
      3. Wound Healing
      4. Dermatology
      5. Cardiovascular Disease & Diabetes
      6. Cell Therapy
      7. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Pharmaceutical & Biotechnology Companies
      2. Research Centers & Academic Institutes
      3. Contract Research & Manufacturing Organizations
    8. Market Attractiveness Analysis
  11. Middle East & Africa Fibroblast Growth Factors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product
      3. By Product Form
      4. By Application
      5. By End User
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
      1. FGF1
      2. FGF2
      3. FGF7
      4. FGF10
      5. FGF19
      6. FGF21
      7. FGF23
      8. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By Product Form, 2025 - 2032
      1. Research Grade
      2. GMP Grade
      3. Finished Formulations
      4. Kits & Diagnostic Reagents
    6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Oncology
      2. Hematology
      3. Wound Healing
      4. Dermatology
      5. Cardiovascular Disease & Diabetes
      6. Cell Therapy
      7. Others
    7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Pharmaceutical & Biotechnology Companies
      2. Research Centers & Academic Institutes
      3. Contract Research & Manufacturing Organizations
    8. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Thermo Fisher Scientific, Inc.
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Merck KGaA
      3. Bio-Rad Laboratories, Inc.
      4. Lonza Group AG
      5. F. Hoffmann-La Roche Ltd.
      6. Bio-Techne Corporation
      7. Abcam PLC (Danaher)
      8. Cell Signaling Technology, Inc.
      9. Creative Bioarray
      10. Proteintech Group, Inc.
      11. Sartorius CellGenix GmbH
      12. GenScript
      13. Miltenyi Biotec.
      14. Sino Biological Inc.
      15. ACROBiosystems
      16. Applied Biological Materials (abm) Inc.
      17. Meridian Bioscience Inc.
      18. Aviva Systems Biology Corporation (GenWay Biotech)
      19. Leadgene Biomedical, Inc.
      20. Boster Bio
      21. Prospec-Tany Technogene Ltd.
      22. AJINOMOTO CO.,INC
      23. STEMCELL Technologies
      24. Akron Biotech
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate